User profiles for Noa Rappaport
Noa RappaportPrincipal Scientist, Institute for Systems Biology Verified email at systemsbiology.org Cited by 6532 |
[HTML][HTML] Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention
Multiomic profiling can reveal population heterogeneity for both health and disease states.
Obesity drives a myriad of metabolic perturbations and is a risk factor for multiple chronic …
Obesity drives a myriad of metabolic perturbations and is a risk factor for multiple chronic …
GeneHancer: genome-wide integration of enhancers and target genes in GeneCards
S Fishilevich, R Nudel, N Rappaport, R Hadar… - Database, 2017 - academic.oup.com
A major challenge in understanding gene regulation is the unequivocal identification of
enhancer elements and uncovering their connections to genes. We present GeneHancer, a …
enhancer elements and uncovering their connections to genes. We present GeneHancer, a …
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
The gut microbiome has important effects on human health, yet its importance in human
ageing remains unclear. In the present study, we demonstrate that, starting in mid-to-late …
ageing remains unclear. In the present study, we demonstrate that, starting in mid-to-late …
[HTML][HTML] MalaCards: an integrated compendium for diseases and their annotation
N Rappaport, N Nativ, G Stelzer, M Twik… - Database, 2013 - academic.oup.com
Comprehensive disease classification, integration and annotation are crucial for biomedical
discovery. At present, disease compilation is incomplete, heterogeneous and often lacking …
discovery. At present, disease compilation is incomplete, heterogeneous and often lacking …
Blood metabolome predicts gut microbiome α-diversity in humans
Depleted gut microbiome α-diversity is associated with several human diseases, but the
extent to which this is reflected in the host molecular phenotype is poorly understood. We …
extent to which this is reflected in the host molecular phenotype is poorly understood. We …
MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search
N Rappaport, M Twik, I Plaschkes, R Nudel… - Nucleic acids …, 2017 - academic.oup.com
The MalaCards human disease database ( http://www.malacards.org/ ) is an integrated
compendium of annotated diseases mined from 68 data sources. MalaCards has a web card for …
compendium of annotated diseases mined from 68 data sources. MalaCards has a web card for …
[HTML][HTML] Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood
X Ojanen, R Cheng, T Törmäkangas, N Rappaport… - …, 2021 - thelancet.com
Background Cardiovascular diseases may originate in childhood. Biomarkers identifying
individuals with increased risk for disease are needed to support early detection and to …
individuals with increased risk for disease are needed to support early detection and to …
The GeneCards suite: from gene data mining to disease genome sequence analyses
…, Y Guan‐Golan, A Kohn, N Rappaport… - Current protocols in …, 2016 - Wiley Online Library
GeneCards, the human gene compendium, enables researchers to effectively navigate and
inter‐relate the wide universe of human genes, diseases, variants, proteins, cells, and …
inter‐relate the wide universe of human genes, diseases, variants, proteins, cells, and …
The transition from genomics to phenomics in personalized population health
Modern health care faces several serious challenges, including an ageing population and
its inherent burden of chronic diseases, rising costs and marginal quality metrics. By …
its inherent burden of chronic diseases, rising costs and marginal quality metrics. By …
GeneAnalytics: an integrative gene set analysis tool for next generation sequencing, RNAseq and microarray data
…, I Plaschkes, A Shitrit, N Rappaport… - Omics: a journal of …, 2016 - liebertpub.com
Postgenomics data are produced in large volumes by life sciences and clinical applications
of novel omics diagnostics and therapeutics for precision medicine. To move from “data-to-…
of novel omics diagnostics and therapeutics for precision medicine. To move from “data-to-…